- Home
- HUBB vs ILMN Comparison
HUBB vs ILMN Comparison
Compare HUBB & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBB
- ILMN
- Stock Information
- Founded
- HUBB 1888
- ILMN 1998
- Country
- HUBB United States
- ILMN United States
- Employees
- HUBB N/A
- ILMN N/A
- Industry
- HUBB Industrial Machinery/Components
- ILMN Medical Specialities
- Sector
- HUBB Technology
- ILMN Health Care
- Exchange
- HUBB Nasdaq
- ILMN Nasdaq
- Market Cap
- HUBB 24.3B
- ILMN 22.9B
- IPO Year
- HUBB N/A
- ILMN 2000
- Fundamental
- Price
- HUBB $457.29
- ILMN $145.15
- Analyst Decision
- HUBB Buy
- ILMN Buy
- Analyst Count
- HUBB 9
- ILMN 20
- Target Price
- HUBB $449.11
- ILMN $160.68
- AVG Volume (30 Days)
- HUBB 427.1K
- ILMN 2.4M
- Earning Date
- HUBB 10-29-2024
- ILMN 11-04-2024
- Dividend Yield
- HUBB 1.15%
- ILMN N/A
- EPS Growth
- HUBB 8.35
- ILMN N/A
- EPS
- HUBB 13.89
- ILMN N/A
- Revenue
- HUBB $5,640,000,000.00
- ILMN $4,390,000,000.00
- Revenue This Year
- HUBB $8.17
- ILMN N/A
- Revenue Next Year
- HUBB $5.08
- ILMN $4.28
- P/E Ratio
- HUBB $32.97
- ILMN N/A
- Revenue Growth
- HUBB 7.50
- ILMN N/A
- 52 Week Low
- HUBB $295.90
- ILMN $97.36
- 52 Week High
- HUBB $481.35
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- HUBB 54.41
- ILMN 53.75
- Support Level
- HUBB $451.78
- ILMN $140.56
- Resistance Level
- HUBB $465.79
- ILMN $146.30
- Average True Range (ATR)
- HUBB 10.71
- ILMN 4.78
- MACD
- HUBB 0.11
- ILMN 0.27
- Stochastic Oscillator
- HUBB 72.15
- ILMN 70.95
About HUBB Hubbell Inc
Hubbell is a diversified conglomerate industrial company that mostly competes in the electrical components market. Its products and services serve vital portions of the U.S. electrical supply chain, including transmission and distribution as well as the commercial, industrial, and residential end markets. The company organizes its business into two segments: Utility Solutions Segment and the Electrical Solutions Segment. It derives maximum revenue from Utility Solutions Segment.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.